Skip to main content
. Author manuscript; available in PMC: 2013 Apr 1.
Published in final edited form as: Steroids. 2012 Jan 20;77(5):477–483. doi: 10.1016/j.steroids.2012.01.007

Figure 3.

Figure 3

Concentration versus time data and model fits of 1,25(OH)2D3 in plasma (circles) and tumor (triangles) after i.p. administration to tumor-bearing nu/nu mice of 20 µg/kg 1,25(OH)2D3 either alone (open symbols, dashed lines) or in combination with 250 µg/kg of the CYP24 inhibitor, CTA091 (solid symbols, solid lines).